Adrian Johnson

TLDR: Investment in tech firms rises to record £143m in 2023 Key Points: Investment into technology firms in Northern Ireland reached a record high of £143.2 million in 2023 across 72 deals.

TLDR: Key Points: Mirador Therapeutics secures over $400 million in early funding rounds to develop precision medicines for immune-related diseases The funding rounds were led by ARCH Venture Partners and included other

TLDR: UK startup ecosystem maintains global prominence despite YoY dip in VC funding in first two months of 2024 $1.4 billion raised across 152 deals in UK, showcasing adaptability and enduring appeal

TLDR: – Foundry, a cloud computing service provider focused on AI workloads, comes out of stealth with a $350 million valuation. – The company has raised $80 million in total seed and

TLDR: P1 Ventures, an African VC firm, has secured $35 million for its second fund. The funding will be used to expand the company’s team in Dakar and Nairobi and focus on

TLDR – Frontline Ventures raises £157m fund for startups looking to expand transatlantic – The funding is split between the Frontline Seed fund and the Frontline Growth fund VC firm Frontline Ventures

TLDR: P1 Ventures completes second close of its second fund at USD 35 million. The investment firm plans to expand its team and operations to Dakar, Senegal, and Nairobi, Kenya, focusing on

TLDR: Amsterdam-based VC OTB Ventures secures €170M to invest in European deep tech startups OTB Ventures has closed its second fund at $185M (approximately €170M) with investments from various entities. The fund

Article Summary TLDR: Mirador Therapeutics secures over $400 million in funding to develop precision medicines for immune-related diseases. The funding rounds, led by ARCH Venture Partners, will allow the company to advance

TLDR: After the success of Prometheus Biosciences, the team returns with a new biotech called Mirador Therapeutics. Mirador Therapeutics raised a massive $400 million in funding to develop precision medicines for inflammatory